The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...

Grace has announced the initial closing of a financing round, securing almost $15m, for funding pre-commercial development of ...

Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive approach to AI.

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.

China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis ...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the ...